KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Inventory: 2018-2024

Historic Inventory for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Dec 2024 value amounting to $6.0 million.

  • Rigel Pharmaceuticals' Inventory rose 178.07% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 178.07%. This contributed to the annual value of $6.0 million for FY2024, which is 8.69% up from last year.
  • As of FY2024, Rigel Pharmaceuticals' Inventory stood at $6.0 million, which was up 8.69% from $5.5 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Inventory ranged from a high of $9.1 million in FY2022 and a low of $1.6 million during FY2020.
  • In the last 3 years, Rigel Pharmaceuticals' Inventory had a median value of $6.0 million in 2024 and averaged $6.9 million.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Inventory skyrocketed by 303.91% in 2021, and later crashed by 39.44% in 2023.
  • Over the past 5 years, Rigel Pharmaceuticals' Inventory (Yearly) stood at $1.6 million in 2020, then skyrocketed by 303.91% to $6.6 million in 2021, then skyrocketed by 37.82% to $9.1 million in 2022, then crashed by 39.44% to $5.5 million in 2023, then grew by 8.69% to $6.0 million in 2024.